Experimental browser for the Atmosphere
Loading post...
{ "uri": "at://did:plc:naykhjvftrs236tkc2ku3ma7/app.bsky.feed.like/3loc4gcndwe2p", "cid": "bafyreihmijxevhtpktw7qitpvgfa5pocffvblgtolhc7tf3aywtaxyqpxq", "value": { "$type": "app.bsky.feed.like", "subject": { "cid": "bafyreietdr2ouxxdfpm4ntqanbdedwtiuelcypsnqyf2avux5dx6vgdeai", "uri": "at://did:plc:plgt5bqnko7dwhzi2436ipuf/app.bsky.feed.post/3llfcjsa3ik2v" }, "createdAt": "2025-05-03T19:51:43.011Z" } }
Patients with Hodgkin lymphoma refractory/intolerant to both BV & checkpoint inhibitors (an increasing reality in the modern era) have median OS 7.4 yrs. This is a new benchmark in novel trials for R/R cHL. Thank you for the opportunity to participate! #lymsm #medsky www.nature.com/articles/s41...
Mar 27, 2025, 10:03 PM